Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Approval sought for Androtest-SL

Jan. 16, 1997

Pharmacia & Upjohn's Estring now available on U.S. market

Jan. 16, 1997

Tokyo Tanabe discloses beta3-adrenoceptor agonists

Jan. 16, 1997

Ion exercises option to license sickle cell anemia Rx

Jan. 14, 1997

Canadian launch for antiobesity drug

Jan. 14, 1997

Genetics Institute reports new bone morphogenic protein

Jan. 14, 1997

Thomae reports agents for hypercholesterolemia

Jan. 14, 1997

Positive phase III results reported for SCF

Jan. 13, 1997

Millennium/Roche obesity collaboration results in another significant discovery

Jan. 13, 1997

New approach to obesity gene research at Lilly

Jan. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...